Protocol Ledger

NCT07012629 · Phase III · RECRUITING

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Interventional Phase III clinical trial protocol NCT07012629 sponsored by Aarhus University Hospital in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-26 Enrollment: 1,652 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07012629
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,652 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07012629
Protocol FieldVerified Registry Value
NCT IdentifierNCT07012629
Consolidated Lead SponsorAarhus University Hospital
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,652 participants (ESTIMATED)
Registered Start Date2025-11-26
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07012629
Hospital Research SiteLocationSite Profile
Aarhus University HospitalAarhus, DenmarkOpen Hospital Dossier ->
RigshospitaletCopenhagen, DenmarkOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI